{"id":"NCT01507896","sponsor":"Baxalta now part of Shire","briefTitle":"BAX 326 Surgery Study in Hemophilia B Patients","officialTitle":"BAX 326 (Recombinant Factor IX): A Phase 3 Prospective, Multicenter Study Evaluating Efficacy and Safety in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level 1-2%) Hemophilia B Undergoing Surgical or Other Invasive Procedures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12-19","primaryCompletion":"2014-05-15","completion":"2014-05-15","firstPosted":"2012-01-11","resultsPosted":"2017-02-15","lastUpdate":"2021-05-19"},"enrollment":30,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia B"],"interventions":[{"type":"BIOLOGICAL","name":"Recombinant factor IX","otherNames":["BAX326","RIXUBIS"]}],"arms":[{"label":"BAX326 in Surgery","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to assess the hemostatic efficacy and safety of BAX 326 in subjects with severe (FIX level \\< 1%) or moderately severe (FIX level 1-2%) hemophilia B undergoing major or minor elective or emergency surgical, dental or other invasive procedures.","primaryOutcome":{"measure":"Intraoperative Hemostatic Efficacy","timeFrame":"On day of surgery","effectByArm":[{"arm":"All Surgeries","deltaMin":37,"sd":null},{"arm":"Major Surgeries","deltaMin":20,"sd":null},{"arm":"Minor Surgeries","deltaMin":17,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":14,"countries":["Argentina","Bulgaria","Chile","Colombia","Czechia","Poland","Romania","Russia","Ukraine","United Kingdom"]},"refs":{"pmids":["24697870","32816519"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Procedural pain","Thrombocytosis","Post procedural swelling","Haemorrhagic anaemia"]}}